Nanobiotix S.A. (NBTX)
NASDAQ: NBTX
· Real-Time Price · USD
8.75
-0.05 (-0.57%)
At close: Aug 19, 2025, 3:55 PM
Nanobiotix S.A. Income Statement
Financials in EUR. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | -20.9M | 9.29M | 32.91M | 3.29M | 1.72M | 664.5K | 664K | 10K |
Cost of Revenue | n/a | n/a | n/a | n/a | 754K | 746K | 759K | -649.5K |
Gross Profit | -20.9M | 9.29M | 32.91M | 3.29M | 969.5K | -81.5K | -95K | 659.5K |
Operating Income | -44.74M | -23.65M | -1.41M | -25.37M | -24.25M | -26.25M | -24.13M | -25.67M |
Interest Income | 2.63M | n/a | n/a | n/a | 250K | 1.36M | 1.22M | 1.56M |
Pretax Income | -46.3M | -21.73M | -11.48M | -28.1M | -33.72M | -27.4M | -17.84M | -31.64M |
Net Income | -46.26M | -21.87M | -11.6M | -28.1M | -30.68M | -26.36M | -16.58M | -30.42M |
Selling & General & Admin | 9.23M | 10.83M | 11.19M | 10.86M | 7.98M | 9.49M | 9.02M | 10M |
Research & Development | 18.55M | 21.99M | 20.59M | 17.8M | 15.53M | 15.94M | 14.35M | 14.88M |
Other Expenses | -3.94M | 121K | 2.55M | -6K | 25K | -68K | n/a | n/a |
Operating Expenses | 23.84M | 32.94M | 34.32M | 28.66M | 23.49M | 25.5M | 23.37M | 24.88M |
Interest Expense | 8.09M | n/a | n/a | n/a | 3.11M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.84M | 32.94M | 34.32M | 28.66M | 24.25M | 26.25M | 24.13M | 25.68M |
Income Tax Expense | -43K | 144K | 117K | 3K | -3.03M | -1.05M | -1.26M | -1.23M |
Shares Outstanding (Basic) | 47.27M | 47.12M | 37.99M | 35.04M | 34.85M | 34.84M | 34.81M | 34.62M |
Shares Outstanding (Diluted) | 47.27M | 47.12M | 38.82M | 35.04M | 34.85M | 34.84M | 34.81M | 34.62M |
EPS (Basic) | -0.98 | -0.46 | -0.3 | -0.8 | -0.88 | -0.76 | -0.48 | -0.88 |
EPS (Diluted) | -0.98 | -0.46 | -0.31 | -0.8 | -0.88 | -0.76 | -0.48 | -0.88 |
EBITDA | -35.08M | -23.24M | 1.41M | -24.64M | -10.26M | -12.09M | -10.55M | -11.78M |
EBIT | -36.41M | -23.53M | 1.14M | -25.38M | -10.4M | -12.46M | -11.4M | -12.18M |
Depreciation & Amortization | 1.33M | 287K | 274K | 741K | 754K | 746K | 759K | 801K |